文献速递产科母胎医学

超重和肥胖孕妇中妊娠期糖尿病对胎儿生长和脂肪量的中介效应:LIMIT随机试验的二次分析

The mediating effects of gestational diabetes on fetal growth and adiposity in women who are overweight and obese: secondary analysis of the LIMIT randomised trial.
PubMed 文献 · BJOG · 2018-06-14

本研究为LIMIT随机试验的二次分析,纳入标准护理组912名BMI≥25 kg/m2的单胎孕妇,采用回归法因果中介分析。结果显示母亲BMI增加与胎儿头围、腹围和估计胎儿体重增加相关,且无证据表明经治疗的妊娠期糖尿病起中介作用;母亲BMI与胎儿脂肪量测量无显著关联。

要点

  • 母亲BMI增加与36周胎儿头围、腹围及估计胎儿体重增加相关,经治疗的妊娠期糖尿病未起中介作用。
  • 母亲BMI与胎儿脂肪量测量之间无显著关联,亦无经治疗妊娠期糖尿病的中介作用。
  • 上述关联是否反映母亲BMI效应饱和或妊娠期糖尿病治疗效应尚不明确。

核心结论

  • 母亲BMI增加与胎儿生长之间存在重要关联,且不经经治疗的妊娠期糖尿病中介;母亲BMI增加与胎儿脂肪量测量无关联,亦无经治疗妊娠期糖尿病的中介作用;这些发现是否反映母亲BMI对胎儿生长效应的饱和或妊娠期糖尿病治疗效应尚不清楚。

研究设计与样本

  • LIMIT随机试验的二次分析,纳入标准护理组912名BMI≥25 kg/m2的单胎孕妇,使用36周胎儿超声测量和基线BMI进行基于回归的因果中介分析。

主要发现

  • 母亲BMI增加与胎儿头围增加相关:直接(非中介)效应0.18(95% CI:0.05-0.31),P=0.005;总效应0.17(95% CI:0.02-0.31),P=0.018。
  • 母亲BMI增加与胎儿腹围增加相关:直接效应0.26(95% CI:0.11-0.41),P=0.001;总效应0.26(95% CI:0.11-0.42),P=0.001。
  • 母亲BMI增加与估计胎儿体重增加相关:直接效应0.22(95% CI:0.08-0.35),P=0.002;总效应0.22(95% CI:0.08-0.35),P=0.002;上述关联均无经治疗妊娠期糖尿病中介的证据。
  • 母亲BMI与胎儿脂肪量测量之间无 apparent 关联,亦无经治疗妊娠期糖尿病的中介作用。

局限性

  • 这些发现是否代表母亲BMI对胎儿生长效应的「饱和」或妊娠期糖尿病治疗的效果尚不清楚。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To describe the mediating effect of maternal gestational diabetes on fetal biometry and adiposity measures among overweight or obese pregnant women. DESIGN: Secondary analysis of the LIMIT randomised trial. SETTING: Public hospitals, metropolitan Adelaide, South Australia. POPULATION: Pregnant women with body mass index (BMI) ≥25 kg/m2 and singleton gestation. METHODS: Fetal ultrasound measures at 36 weeks of gestation and baseline BMI from women randomised to the LIMIT trial Standard Care group (n = 912 women) were used to conduct causal mediation analyses using regression-based methods. MAIN OUTCOMES MEASURES: Ultrasound measures of fetal biometry and adiposity at 36 weeks of gestation. RESULTS: Increased maternal BMI was associated with increased measures of fetal head circumference [direct (unmediated) effect 0.18 (95% CI: 0.05-0.31), P = 0.005; total effect 0.17 (95% CI: 0.02-0.31), P = 0.018], abdominal circumference [direct effect 0.26 (95% CI: 0.11-0.41), P = 0.001; total effect 0.26 (95% CI: 0.11-0.42), P = 0.001] and estimated fetal weight [direct effect 0.22 (95% CI: 0.08-0.35), P = 0.002; total effect 0.22 (95% CI: 0.08-0.35), P = 0.002], with no evidence of mediation by treated gestational diabetes. There was no apparent association between maternal BMI and fetal adiposity measures, or mediation by treated gestational diabetes. CONCLUSIONS: We show an important association between increased maternal BMI and fetal growth, not mediated by treated gestational diabetes. There was no association between increased maternal BMI and fetal adiposity measures, or mediation by treated gestational diabetes. Whether these findings represent 'saturation' in the effect of maternal BMI on fetal growth or the effect of treatment of GDM is unclear. FUNDING: This project was funded by a 4-year project grant from the National Health and Medical Research Council (NHMRC), Australia (ID 519240); The Channel 7 Children's Research Foundation, South Australia; and the US National Institutes of Health (R01 HL094235-01). TWEETABLE ABSTRACT: Increased fetal growth associated with maternal obesity is not mediated by gestational diabetes.

来源:BJOG,查看原文。版权归原作者所有。

引用

  1. Poprzeczny AJ, Louise J, Deussen AR, et al. The mediating effects of gestational diabetes on fetal growth and adiposity in women who are overweight and obese: secondary analysis of the LIMIT randomised trial. BJOG. 2018. PMID: 29782075. doi:10.1111/1471-0528.15288

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。